Objective: To observe the state of breast development of the healthy females of the right age in different regions. Methods: We randomly chose 1540 of 18 -25 years old unmarried or married healthy females of the right age from both Guangxi and Yunnan provinces separately for regular checkups. Also we took notes on these females' height and chest circumference and other indexes. According to the perfect chest circumference of Chinese females in relation to height, namely this relational expression-Standard Circumference = Height × 0.53, we evaluated the basic state of breast development of females from the two areas and then presented related research conclusions. Results: After the statistical analyses on every index of 1540 cases of healthy females of the right age from the two areas each, we found that the breast development of healthy women of the right age in Yunnan is more perfect than that of Guangxi, and in comparison to every index, there is a remarkable difference, and that is, P < 0.01. Conclusions: The state of breast development of healthy females of the right age is different in different areas. Some breasts are especially big; some are a little bit smaller; some are proper and some are relatively flat; also some breasts are strong while some are pendulous. In a word, there are some differences. These differences exist not only in China but also in every part of the world. The female whose chest circumference tends to be more close to the perfect is more likely to be more confident and more active, and also her life is full of sensibility and charm.
Object: To explore a better treatment on the female urogenital tract mycoplasma infection so as to ensure the health of female reproduction. Method: 115 female patients with urogenital tract mycoplasma infection are selected, including 63 patients acted as a group for intermittent medication treatment; that is to say, the ones that are confirmed to be sensitive drugs to those 63 patients are chosen, and let them take this medication for 15 days and stop taking it for 7 days and after that continue to take it for 10 days. The other 52 patients in the other group which acts as a contrast to the former group are cured with a course of conventional treatment for 15-21 days. Results: As to those 115 female patients with urogenital tract mycoplasma infection, 43 patients get relapsed, and 27 patients of them are in the contrast group and 16 patients are in the treatment group. There is obvious difference on the contrast of relapse rate between the treatment group and contrast group, and they are P < 0.01. But as to the sensitive testing results of 10 common antibiotic medicines, there are cases of illness of relapse in those 2 groups, and the rate of drug sensitivity in the treatment group is higher than that of the contrast group. Between treatment group and contrast group, there is obvious difference in the sensitivity of the drugs, P < 0.05 average. Conclusion: When the female patients with urogenital tract mycoplasma infection are cured with a traditional treatment, because of the side effects of drugs, they are not likely to take medicines that are required to making the cure rate become lower and the relapse rate become higher. But intermittent medication is designed with the half-life period of medicine, which makes the medicine can be digested and absorbed easily, and the cure rate is high and the relapse rate is low. With this research we found a more effective method of the treatment on the female urogenital tract mycoplasma infection and showed the clinical significance in intermittent medication.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.